Publication | Closed Access
Intravesical bacillus calmette-gueÈrin for the treatment of superficial bladder cancer in renal transplant patients
83
Citations
6
References
2003
Year
Intravesical BCG in superficial bladder cancer and/or CIS is a valid option, with no added morbidity to renal transplant patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1